Literature DB >> 22223142

Deficient expression of genes involved in the endogenous defense system against transposons in cryptorchid boys with impaired mini-puberty.

Faruk Hadziselimovic1, N O Hadziselimovic, P Demougin, G Krey, E J Oakeley.   

Abstract

Mini-puberty is the period between 30 and 80 days after birth when testosterone and gonadotropin surges occur in male infants to induce the transformation of gonocytes into adult/dark spermatogonia. Cryptorchid boys with impaired mini-puberty develop infertility despite timely and successful surgical treatment. The decreased germ cell count found in this group of boys could be the result of uncontrolled transposon activity inducing genomic instability and germ cell death. A genome-wide analysis of 18 cryptorchid and 4 control testes was performed with Affymetrix chips. We found that 5 of 8 genes that are important for transposon silencing were not expressed in the high azoospermia risk group of cryptorchid boys but were expressed in the low azoospermia risk and control groups. Two genes, CBX3 and DNMT1, were equally expressed in all 3 groups. Impaired expression of the DDX4, MAEL,MOV10L1, PIWIL2, PIWIL4, and TDRD9 genes in the group of cryptorchid boys at high risk of infertility indicates that gene instability induced by impaired expression of transposon silencing genes contribute to the development of azoospermia. Intact mini-puberty appears to be essential for the development of the endogenous defense system mediated by transposon silencing.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22223142     DOI: 10.1159/000335188

Source DB:  PubMed          Journal:  Sex Dev        ISSN: 1661-5425            Impact factor:   1.824


  9 in total

Review 1.  Mini puberty and its interpretation.

Authors:  Selim Kurtoğlu; Osman Baştuğ
Journal:  Turk Pediatri Ars       Date:  2014-09-01

Review 2.  A novel role for CFTR interaction with LH and FGF in azoospermia and epididymal maldevelopment caused by cryptorchidism.

Authors:  Faruk Hadziselimovic; Gilvydas Verkauskas; Michael Stadler
Journal:  Basic Clin Androl       Date:  2022-06-21

Review 3.  Male Reproductive Disorders and Fertility Trends: Influences of Environment and Genetic Susceptibility.

Authors:  Niels E Skakkebaek; Ewa Rajpert-De Meyts; Germaine M Buck Louis; Jorma Toppari; Anna-Maria Andersson; Michael L Eisenberg; Tina Kold Jensen; Niels Jørgensen; Shanna H Swan; Katherine J Sapra; Søren Ziebe; Lærke Priskorn; Anders Juul
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 4.  Undescended testicle: An update on fertility in cryptorchid men.

Authors:  Prabudh Goel; J D Rawat; A Wakhlu; S N Kureel
Journal:  Indian J Med Res       Date:  2015-02       Impact factor: 2.375

5.  Investigation of piwi-interacting RNA pathway genes role in idiopathic non-obstructive azoospermia.

Authors:  Zeeba Kamaliyan; Sara Pouriamanesh; Mohsen Soosanabadi; Milad Gholami; Reza Mirfakhraie
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

Review 6.  On the descent of the epididymo-testicular unit, cryptorchidism, and prevention of infertility.

Authors:  Faruk Hadziselimovic
Journal:  Basic Clin Androl       Date:  2017-11-14

7.  Association of PIWIL4 genetic variants with germ cell maturation arrest in infertile Spanish men.

Authors:  Xavi Muñoz; Mercedes Navarro; Ana Mata; Lluís Bassas; Sara Larriba
Journal:  Asian J Androl       Date:  2014 Nov-Dec       Impact factor: 3.285

8.  PRDM Histone Methyltransferase mRNA Levels Increase in Response to Curative Hormone Treatment for Cryptorchidism-Dependent Male Infertility.

Authors:  Faruk Hadziselimovic; Gieri Cathomas; Gilvydas Verkauskas; Darius Dasevicius; Michael B Stadler
Journal:  Genes (Basel)       Date:  2018-08-01       Impact factor: 4.096

Review 9.  Fertility of Cryptorchid Testis-An Unsolved Mistery.

Authors:  Carmen Iulia Ciongradi; Ioan Sârbu; Codruța Olimpiada Iliescu Halițchi; Diana Benchia; Klara Sârbu
Journal:  Genes (Basel)       Date:  2021-11-26       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.